Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea · Delayed Price · Currency is KRW 46,350
+3,700 (8.68%)
At close: Nov 26, 2025
30.20% (1Y)
| Market Cap | 2.16T |
| Revenue (ttm) | 154.05B |
| Net Income (ttm) | 2.31B |
| Shares Out | 50.75M |
| EPS (ttm) | 46.29 |
| PE Ratio | 936.97 |
| Forward PE | 299.40 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,274,012 |
| Average Volume | 1,379,638 |
| Open | 43,050 |
| Previous Close | 42,650 |
| Day's Range | 43,050 - 47,500 |
| 52-Week Range | 24,000 - 49,600 |
| Beta | 0.78 |
| RSI | 60.44 |
| Earnings Date | Nov 14, 2025 |